CO-SPONSORS


AHNS

ASCO

ASTRO

Multidisciplinary Head and Neck Cancer Symposium - January 26-28, 2012
Arizona Biltmore, Phoenix

The Multidisciplinary Head and Neck Cancer Symposium is your ideal opportunity to explore the heterogeneous group of tumors in head and neck cancers, and the various complexities and factors in providing treatment. Discover the multidisciplinary approach involving surgery, radiation therapy and chemotherapy as mainstays of treatment for head and neck cancer patients, in addition to novel molecular biologic therapies showing promise in improving outcomes. 

Join us for this two-and-a-half day meeting as we offer interactive, educational sessions focusing on topics such as supportive care, directed therapy, new surgical and radio-therapeutic techniques, as well as oral abstract sessions highlighting the most current, cutting-edge science of relevance to the head and neck community. 


Needs Statement

Oncologists find treatment of head and neck cancer patients challenging for many reasons including patient quality of life, lack of familiarity with standards of care and changing epidemiology, as well as relatively low survival rates. Poor prognosis is primarily due to recurrence, secondary malignancies, and co-morbidities. Controversies remain in regards to the optimal treatment approaches based on stage and more recently, smoking and HPV status.

Complexities in the treatment of head and neck cancers call for a multidisciplinary approach. Managing these difficult to treat patients at experienced, high-volume cancer centers can impact outcomes. Oncology specialists within the community and academic setting require additional education to expand their expertise in improving the quality of life and outcomes in head and neck cancer patients.


Objectives

  1. Discuss the changing epidemiology of head and neck cancers and its effect on patient management.
  2. Report the latest advances in the management of head and neck cancer within the various oncologic specialties.
  3. Identify new technologies designed to minimize treatment morbidity.
  4. Evaluate the role of the multidisciplinary team in management.
  5. Explore and evaluate outcomes and effectiveness of clinical management standards.

Target Audience

Medical Oncologists
Radiation Oncologists
Surgeons
Physicists
Nurses
Diagnostic Radiologists
Pathologists
Radiation Therapists
Radiation Dosimetrists
Specialists (i.e., Dentists, ENT)
Laboratory Researchers
Mid-level Providers